Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.89 |
| ▸ | HTT | P42858 | 2/20 | 0.62 |
| ▸ | LPAR5 | Q9H1C0 | 4/20 | 0.54 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | LPAR1 | Q92633 | 5/20 | 0.42 |
| ▸ | LPAR3 | Q9UBY5 | 5/20 | 0.42 |
| ▸ | LPAR2 | Q9HBW0 | 4/20 | 0.42 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.42 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ether SCHEMBL6805057 | 1.00 | USP2 (0.89) | USP2HTTLPAR5PLA2G2CMEN1 | |
| Ether SCHEMBL2015031 | 1.00 | USP2 (0.89) | USP2HTTLPAR5PLA2G2CMEN1 | |
| Ether SCHEMBL93806 | 1.00 | USP2 (0.89) | USP2HTTLPAR5PLA2G2CMEN1 | |
| Ether SCHEMBL8501744 | 1.00 | USP2 (0.89) | USP2HTTLPAR5PLA2G2CMEN1 | |
| Ether SCHEMBL6428915 | 1.00 | USP2 (0.89) | USP2HTTLPAR5PLA2G2CMEN1 | |
| Ether SCHEMBL2390477 | 1.00 | USP2 (0.89) | USP2HTTLPAR5PLA2G2CMEN1 | |
| Ether SCHEMBL8502252 | 1.00 | USP2 (0.89) | USP2HTTLPAR5PLA2G2CMEN1 | |
| Ether SCHEMBL3811088 | 1.00 | USP2 (0.89) | USP2HTTLPAR5PLA2G2CMEN1 | |
| Ether SCHEMBL8501725 | 0.98 | USP2 (0.85) | USP2HTTLPAR5PLA2G2CMEN1 | |
| SCHEMBL24835077 | 0.94 | USP2 (1.00) | USP2HTTLPAR5PLA2G2CMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011084430-A1 | COMPOSITION AND METHOD FOR REDUCING FRICTION IN INTERNAL COMBUSTION ENGINES | BP CORPORATION NORTH AMERICA INC. (US) | 2011-07-14 | — | — | WO | claimed |
| US-20110146144-A1 | Composition and Method for Reducing Friction in Internal Combustion Engines | BP CORPORATION NORTH AMERICA INC. (US) | 2011-06-23 | — | — | US | claimed |
| US-20040208783-A1 | Process for the chemical and thermal disinfection | AIR LIQUIDE SANTE (INTERNATIONAL ) (FR) | 2004-10-21 | — | — | US | claimed |
| EP-1468606-A1 | Process for the chemical and thermal disinfection | Air Liquide Santé (International) (FR) | 2004-10-20 | — | — | EP | claimed |
| WO-2024058214-A1 | SOLID EMULSIFIER FOR OIL-IN-WATER TYPE EMULSION, PRODUCTION METHOD OF OIL-IN-WATER TYPE EMULSION, OIL-IN-WATER TYPE EMULSION AND COSMETIC COMPOSITION | 三洋化成工業株式会社 | 2024-03-21 | — | — | WO | disclosed |
| US-20220000758-A1 | COSMETIC | SHISEIDO COMPANY, LTD. (JP) | 2022-01-06 | — | — | US | disclosed |
| US-20220001443-A1 | POWDER DISPERSION COMPOSITION AND DISPERSING METHOD THEREOF | SHISEIDO COMPANY, LTD. (JP) | 2022-01-06 | — | — | US | disclosed |
| EP-3881820-A1 | POWDER DISPERSION COMPOSITION AND DISPERSING METHOD THEREOF | Shiseido Company, Ltd. (JP) | 2021-09-22 | — | — | EP | disclosed |
| EP-3881899-A1 | COSMETIC | Shiseido Company, Ltd. (JP) | 2021-09-22 | — | — | EP | disclosed |
| EP-2292208-B1 | EXTERNAL PREPARATION FOR SKIN | SHISEIDO CO LTD (JP) | 2017-07-19 | — | — | EP | disclosed |
| US-20140120051-A1 | Skin Cosmetic | SHISEIDO COMPANY, LTD. (JP) | 2014-05-01 | — | — | US | disclosed |
| US-8642023-B2 | Skin cosmetic | SHISEIDO COMPANY, LTD. (JP) | 2014-02-04 | — | — | US | disclosed |
| US-6169114-B1 | STORAGE STABILITY, THIOL COMPOUND IS ONE OR MORE TYPES OF CYSTEINE AND ITS DERIVATIVES, ZINC OXIDE HAVING A WATER REPELLANT TREATMENT ON ITS SURFACE, | SHISEIDO COMPANY, LTD. (JP) | 2001-01-02 | — | — | US | disclosed |
| EP-0976381-A1 | DERMATOLOGIC PREPARATION | SHISEIDO COMPANY LIMITED (JP) | 2000-02-02 | — | — | EP | disclosed |
| EP-0941087-A1 | TOPICAL FORMULATIONS CONTAINING AS A THERAPEUTIC ACTIVE AGENT FATTY ACIDS OR FATTY ALCOHOLS OR MONOGLYCERIDE DERIVATIVES THEREOF FOR TREATING OF MUCOSA INFECTIONS | Thormar, Halldor (IS) | 1999-09-15 | — | — | EP | disclosed |
| US-5849834-A | W/O type emulsified composition and cosmetic | SHISEIDO CO., LTD. (JP) | 1998-12-15 | — | — | US | disclosed |
| US-5767158-A | FOR BLEACHING SKIN | SHISEIDO CO., LTD. (JP) | 1998-06-16 | — | — | US | disclosed |
| WO-1998020872-A1 | TOPICAL FORMULATIONS CONTAINING AS A THERAPEUTIC ACTIVE AGENT FATTY ACIDS OR FATTY ALCOHOLS OR MONOGLYCERIDE DERIVATIVES THEREOF FOR TREATING OF MUCOSA INFECTIONS | THORMAR HALLDOR (IS) | 1998-05-22 | — | — | WO | disclosed |
| EP-0795318-A2 | A w/o cosmetic emulsion containing ethylcellulose | SHISEIDO COMPANY LIMITED (JP) | 1997-09-17 | — | — | EP | disclosed |
| EP-0728469-A2 | An endermic liniment | SHISEIDO COMPANY LIMITED (JP) | 1996-08-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220000758-A1 | COSMETIC | CUTA, SQLE, FDFT1 | USP2 3492/4885HTT 1706/4885LPAR5 1187/4885 |
| US-20140120051-A1 | Skin Cosmetic | CUTA, SMC3, H1-0 | USP2 411/4885HTT 2440/4885LPAR5 2137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.